| 9/1/2020 |
Lumen Bioscience Raises $16M Series B Financing to Accelerate Clinical Development of Accessible Biologic Drugs |
| 7/23/2020 |
Lumen Wins Triple Funding Boost to Advance Development of Low-Cost Therapeutics for Newborns and Infants in Developing Countries |
| 7/23/2020 |
Dr. Craig Behnke Joins Lumen Bioscience as SVP, Production and Development |
| 7/23/2020 |
Lumen Bioscience Announces Issuance of US Patent for Genetic Modification of Spirulina |
| 7/8/2020 |
NIH Awards Grant to Lumen Bioscience for Cost-Effective Oral Malaria Vaccine |
| 4/1/2020 |
Lumen Wins Grant to Develop Ultra-Low-Cost Therapeutics for Treating Infant Diseases in Developing Countries |
